BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2250145)

  • 1. Involvement of dopamine D1 receptors in the control of growth hormone secretion in the rat.
    Bluet-Pajot MT; Mounier F; Durand D; Kordon C
    J Endocrinol; 1990 Nov; 127(2):191-6. PubMed ID: 2250145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential actions of dopamine receptor subtypes on gonadotropin and growth hormone release in vitro in goldfish.
    Chang JP; Yu KL; Wong AO; Peter RE
    Neuroendocrinology; 1990 Jun; 51(6):664-74. PubMed ID: 2141920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
    Wong AO; Chang JP; Peter RE
    Endocrinology; 1992 Mar; 130(3):1201-10. PubMed ID: 1347006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M
    J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes.
    Curlewis JD; Clarke IJ; McNeilly AS
    J Endocrinol; 1993 Jun; 137(3):457-64. PubMed ID: 8371076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation.
    West CR; Lookingland KJ; Tucker HA
    Domest Anim Endocrinol; 1997 Sep; 14(5):349-57. PubMed ID: 9347255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation by dopamine receptors of the histamine release in the rat hypothalamus.
    Prast H; Heistracher M; Philippu A
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):301-5. PubMed ID: 7683115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic 3',5'-adenosine monophosphate mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells.
    Wong AO; van der Kraak G; Chang JP
    Neuroendocrinology; 1994 Oct; 60(4):410-7. PubMed ID: 7529899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evidence that dopamine exerts growth hormone-releasing activity in goldfish.
    Wong AO; Chang JP; Peter RE
    Am J Physiol; 1993 Jun; 264(6 Pt 1):E925-32. PubMed ID: 8101429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D1 and D2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis.
    Kurata K; Shibata R
    Neurosci Lett; 1991 Nov; 133(1):77-80. PubMed ID: 1686482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.